Dexcom Stelo: what is it and who is it for in 2026?

What Stelo officially is

Dexcom Stelo continues to fill in 2026 because on March 5, 2024, the FDA cleared the system as the first over-the-counter integrated continuous glucose monitor for people 18 and older who do not use insulin. Officially, it is an app-connected biosensor system that continuously measures, records and displays glucose values ​​without a prescription. FDA Stelo by Dexcom

That puts Stelo in a different place than classic prescription CGMs for diabetes management. Dexcom describes the product as a tool to better understand how diet, exercise and behavior affect glucose excursion. Each sensor is specified for up to 15 days of use with a 12-hour grace period, but the manufacturer itself describes the lifetime as 'up to' and not as a guarantee for full wear time. FDA Stelo by Dexcom

Who can use it, but who should hold back

The best user profile is not just 'everyone who is curious about biohacking', but adults with a specific question. It could be what happens after a certain breakfast, whether a late dinner causes more anxiety, or whether a short walk actually moves the curve in the right direction. Without a question, there is a high risk that Stelo will become just another habit of looking at numbers. Stelo by Dexcom Stelo by Dexcom

The official safety information is as important as the marketing layer. Stelo is not designed for people with problematic hypoglycemia, has not been evaluated for use during dialysis, and the user should not make medication adjustments or other medical actions based on sensor output alone. Stelo by Dexcom Stelo by Dexcom

For Danish readers, there is also a practical limit: Stelo is currently only sold in the USA, and Dexcom states that both app setup and primary residence must be American. It is therefore an important market signal and a relevant reference article, but not the same as broad local availability in Denmark. Stelo by Dexcom Stelo by Dexcom

What you can realistically learn from Stelo

When Stelo is used judiciously, the strength is not a single number, but repeated patterns. You can see how the same type of meal, a short walk, less sleep or a late dinner moves the curve over several days. This makes the Dexcom Stelo relevant as an entry point to CGM without diabetes, not as a finding machine. Stelo by Dexcom Stelo by Dexcom

The most useful use is therefore often circumscribed: test a hypothesis, iterate, adjust and stop again. If the goal is to understand insulin resistance or metabolic syndrome, the sensor makes the most sense as a supplement to HbA1c, fasting glucose, blood pressure and body composition rather than as a replacement for them. Stelo by Dexcom Stelo by Dexcom

What Stelo cannot decide alone

Stelo alone cannot determine whether you have diabetes, insulin resistance or the need for treatment. The FDA states directly that users should not make medical decisions based on the output without talking to a healthcare professional. This is an important limit in a market where much content still sounds as if the sensor is a mini-diagnosis in your pocket. Stelo by Dexcom

Dexcom's own support team says the same in more practical terms: if your symptoms don't match the reading, or if the sensor doesn't show a number, a blood glucose meter may be relevant as needed. It's an important corrective to the type of tracking culture where the app is treated as objective truth in real time. Stelo by Dexcom

When Stelo becomes more noise than insight

Stelo quickly loses value if you start chasing perfect curves, cutting out entire food groups out of fear, or checking the app without a real decision in mind. This is exactly where an otherwise useful product slips from learning to control. Stelo by Dexcom

The more sustainable strategy is to use the sensor as a temporary learning tool. Once the clearest patterns are found, good blood tests, more stable sleep, better meal structure or more exercise can often yield greater benefits than another month of constant glucose monitoring. Stelo by Dexcom